Laurus Labs Performance dei guadagni passati

Il passato criteri di controllo 1/6

Gli utili di Laurus Labs sono diminuiti a un tasso medio annuo di -6.1%, mentre il settore Pharmaceuticals ha visto gli utili crescere a un tasso medio annuo di 13.4%. I ricavi sono cresciuti crescere a un tasso medio annuo di 11.5%. Il ritorno sul capitale proprio di Laurus Labs è 3.2% e ha margini netti di 2.6%.

Informazioni chiave

-6.1%

Tasso di crescita degli utili

-6.2%

Tasso di crescita dell'EPS

Pharmaceuticals Crescita del settore	17.5%
Tasso di crescita dei ricavi	11.5%
Rendimento del capitale proprio	3.2%
Margine netto	2.6%
Ultimo aggiornamento sui guadagni	30 Sep 2024

Aggiornamenti sulle prestazioni recenti

Recent updates

Laurus Labs (NSE:LAURUSLABS) Is Due To Pay A Dividend Of ₹0.40

Oct 28

Laurus Labs (NSE:LAURUSLABS) Takes On Some Risk With Its Use Of Debt

Oct 26

Here's Why It's Unlikely That Laurus Labs Limited's (NSE:LAURUSLABS) CEO Will See A Pay Rise This Year

Jul 05

Laurus Labs Limited's (NSE:LAURUSLABS) Price In Tune With Revenues

Jul 03

Laurus Labs' (NSE:LAURUSLABS) Dividend Will Be ₹0.40

Apr 28

Laurus Labs Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Jan 27

Is Laurus Labs (NSE:LAURUSLABS) A Risky Investment?

Dec 01

Laurus Labs (NSE:LAURUSLABS) Is Paying Out Less In Dividends Than Last Year

Oct 22

These 4 Measures Indicate That Laurus Labs (NSE:LAURUSLABS) Is Using Debt Reasonably Well

Jul 06

Laurus Labs (NSE:LAURUSLABS) Is Paying Out A Dividend Of ₹1.20

Apr 30

Is Laurus Labs (NSE:LAURUSLABS) A Risky Investment?

Dec 18

Is Laurus Labs Limited (NSE:LAURUSLABS) Expensive For A Reason? A Look At Its Intrinsic Value

Sep 27

I Ran A Stock Scan For Earnings Growth And Laurus Labs (NSE:LAURUSLABS) Passed With Ease

Nov 12

Laurus Labs (NSE:LAURUSLABS) Has Affirmed Its Dividend Of ₹0.80

Oct 30

A Look At The Intrinsic Value Of Laurus Labs Limited (NSE:LAURUSLABS)

Oct 05

Should You Be Adding Laurus Labs (NSE:LAURUSLABS) To Your Watchlist Today?

Aug 10

Laurus Labs (NSE:LAURUSLABS) Seems To Use Debt Quite Sensibly

Jul 23

Is Laurus Labs Limited (NSE:LAURUSLABS) Worth ₹547 Based On Its Intrinsic Value?

Jun 06

Ripartizione dei ricavi e delle spese

Come Laurus Labs guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.

Storia dei guadagni e delle entrate

NSEI:LAURUSLABS Ricavi, spese e utili (INR Millions )
Data	Ricavi	Guadagni	Spese G+A
30 Sep 24	50,532	1,311	6,817
30 Jun 24	50,540	1,482	6,669
31 Mar 24	50,408	1,606	6,529
31 Dec 23	49,821	1,879	6,320
30 Sep 23	53,320	3,678	6,244
30 Jun 23	56,834	5,637	6,074
31 Mar 23	60,406	7,901	5,995
31 Dec 22	60,845	9,176	5,786
30 Sep 22	55,684	8,683	5,532
30 Jun 22	51,960	8,374	5,291
31 Mar 22	49,356	8,275	5,043
31 Dec 21	49,227	8,937	4,899
30 Sep 21	51,823	10,128	4,685
30 Jun 21	51,177	10,532	4,537
31 Mar 21	48,135	9,836	4,380
31 Dec 20	42,407	7,971	4,190
30 Sep 20	36,819	5,977	4,068
30 Jun 20	32,555	4,120	3,866
31 Mar 20	28,317	2,553	3,554
31 Dec 19	26,277	1,883	3,452
30 Sep 19	24,276	1,326	3,257
30 Jun 19	23,035	923	3,112
31 Mar 19	22,919	938	3,037
31 Dec 18	22,170	957	2,942
30 Sep 18	21,665	1,127	2,901
30 Jun 18	21,168	1,453	2,800
31 Mar 18	20,562	1,676	2,699
31 Dec 17	19,687	1,917	2,870
30 Sep 17	19,954	2,019	2,772
30 Jun 17	19,733	2,014	2,673
31 Mar 17	19,046	1,881	2,349
31 Mar 16	17,776	1,337	1,983
31 Mar 15	13,266	684	1,748
31 Mar 14	11,597	972	1,473

Guadagni di qualità: LAURUSLABS ha guadagni di alta qualità.

Margine di profitto in crescita: Gli attuali margini di profitto netti di LAURUSLABS (2.6%) sono inferiori rispetto allo scorso anno (6.9%).

Flusso di cassa libero e analisi degli utili

Analisi della crescita degli utili nel passato

Andamento degli utili: Gli utili di LAURUSLABS sono diminuiti del 6.1% all'anno negli ultimi 5 anni.

Accelerare la crescita: LAURUSLABS ha avuto una crescita negativa degli utili nell'ultimo anno, quindi non può essere confrontata con la sua media quinquennale.

Guadagni vs Settore: LAURUSLABS ha avuto una crescita negativa degli utili ( -64.4% ) nell'ultimo anno, rendendo difficile il confronto con la media del settore Pharmaceuticals ( 20% ).

Laurus Labs Performance dei guadagni passati

Il passato criteri di controllo 1/6

Informazioni chiave

Aggiornamenti sulle prestazioni recenti

Second quarter 2025 earnings: EPS and revenues miss analyst expectations

Laurus Labs Limited to Report Q2, 2025 Results on Oct 24, 2024

First quarter 2025 earnings: EPS and revenues miss analyst expectations

Laurus Labs Limited to Report Q1, 2025 Results on Jul 25, 2024

Full year 2024 earnings: EPS misses analyst expectations

Full year 2024 earnings: EPS misses analyst expectations

Recent updates

Consensus EPS estimates fall by 12%

Laurus Labs (NSE:LAURUSLABS) Is Due To Pay A Dividend Of ₹0.40

First half dividend of ₹0.40 announced

Laurus Labs (NSE:LAURUSLABS) Takes On Some Risk With Its Use Of Debt

Second quarter 2025 earnings: EPS and revenues miss analyst expectations

Laurus Labs Limited Approves Interim Dividend for the Financial Year 2024- 2025

Laurus Labs Limited to Report Q2, 2025 Results on Oct 24, 2024

Laurus Labs Limited Appoints Ramesh Subrahmanian as A Non-Executive Independent Director

First quarter 2025 earnings: EPS and revenues miss analyst expectations

Laurus Labs Limited to Report Q1, 2025 Results on Jul 25, 2024

Laurus Labs Limited Announces Board Appointments

Here's Why It's Unlikely That Laurus Labs Limited's (NSE:LAURUSLABS) CEO Will See A Pay Rise This Year

Laurus Labs Limited's (NSE:LAURUSLABS) Price In Tune With Revenues

Full year 2024 earnings: EPS misses analyst expectations

Less than half of directors are independent

Less than half of directors are independent

Laurus Labs' (NSE:LAURUSLABS) Dividend Will Be ₹0.40

Final dividend reduced to ₹0.40

Laurus Labs Limited, Annual General Meeting, Jul 11, 2024

Full year 2024 earnings: EPS misses analyst expectations

Laurus Labs Limited Approves Board Changes

Laurus Labs Limited to Report Q4, 2024 Results on Apr 25, 2024

Laurus Labs Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Laurus Labs Limited to Report Q3, 2024 Results on Jan 24, 2024

Is Laurus Labs (NSE:LAURUSLABS) A Risky Investment?

Consensus EPS estimates fall by 34%

Upcoming dividend of ₹0.40 per share at 0.4% yield

Price target increased by 7.2% to ₹371

Laurus Labs (NSE:LAURUSLABS) Is Paying Out Less In Dividends Than Last Year

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Laurus Labs Limited Approves Interim Dividend, Payable on or After November 09, 2023

Laurus Labs Limited to Report Q2, 2024 Results on Oct 20, 2023

Laurus Labs Limited (NSEI:LAURUSLABS) agreed to acquire an additional 14.54% stake in Laurus Bio Private Limited from one of the Promoters, non-executive director, his family members and few Employee/ex-Employee shareholders for approximately INR 720 million.

Investor sentiment improves as stock rises 16%

Consensus EPS estimates fall by 10%

New minor risk - Profit margin trend

First quarter 2024 earnings released: EPS: ₹0.46 (vs ₹4.68 in 1Q 2023)

These 4 Measures Indicate That Laurus Labs (NSE:LAURUSLABS) Is Using Debt Reasonably Well

Full year 2023 earnings: EPS and revenues miss analyst expectations

Laurus Labs Limited (NSEI:LAURUSLABS) signed an investment agreement to acquire additional 7.24% stake in Immunoadoptive Cell Therapy Private Limited for INR 800 million.

Upcoming dividend of ₹1.20 per share at 0.6% yield

Price target decreased by 11% to ₹382

Laurus Labs (NSE:LAURUSLABS) Is Paying Out A Dividend Of ₹1.20

Full year 2023 earnings: EPS and revenues miss analyst expectations

Price target decreased by 10% to ₹470

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Laurus Labs Limited to Report Q3, 2023 Results on Jan 30, 2023

Is Laurus Labs (NSE:LAURUSLABS) A Risky Investment?

Laurus Labs Limited announced that it expects to receive INR 38.998 million in funding from Ethan Energy India Private Limited

Insufficient new directors

Upcoming dividend of ₹0.80 per share

Price target decreased to ₹574

Laurus Labs Limited Approves Interim Dividend for the Financial Year 2022-2023, Payable on or After November 15, 2022

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

Laurus Labs Limited to Report Q2, 2023 Results on Oct 21, 2022

Is Laurus Labs Limited (NSE:LAURUSLABS) Expensive For A Reason? A Look At Its Intrinsic Value

Is Laurus Labs (NSE:LAURUSLABS) Using Too Much Debt?

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Laurus Labs Limited to Report Q1, 2023 Results on Jul 27, 2022

Investor sentiment deteriorated over the past week

Laurus Labs (NSE:LAURUSLABS) Has A Somewhat Strained Balance Sheet

Full year 2022 earnings: Revenues and EPS in line with analyst expectations

Upcoming dividend of ₹1.20 per share

Laurus Labs (NSE:LAURUSLABS) Is Paying Out A Larger Dividend Than Last Year

Full year 2022 earnings: Revenues and EPS in line with analyst expectations

Insufficient new directors

Laurus Labs Limited to Report Q4, 2022 Results on Apr 28, 2022

Laurus Labs (NSE:LAURUSLABS) Seems To Use Debt Quite Sensibly